chr6-123393624-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_006073.4(TRDN):c.1105G>A(p.Ala369Thr) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000106 in 1,602,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006073.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRDN | NM_006073.4 | c.1105G>A | p.Ala369Thr | missense_variant, splice_region_variant | 13/41 | ENST00000334268.9 | NP_006064.2 | |
TRDN | NM_001251987.2 | c.1108G>A | p.Ala370Thr | missense_variant, splice_region_variant | 13/21 | NP_001238916.1 | ||
TRDN | NM_001407315.1 | c.1048G>A | p.Ala350Thr | missense_variant, splice_region_variant | 12/20 | NP_001394244.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRDN | ENST00000334268.9 | c.1105G>A | p.Ala369Thr | missense_variant, splice_region_variant | 13/41 | 1 | NM_006073.4 | ENSP00000333984 | A2 | |
TRDN-AS1 | ENST00000587106.6 | n.55+4149C>T | intron_variant, non_coding_transcript_variant | 5 | ||||||
TRDN | ENST00000662930.1 | c.1108G>A | p.Ala370Thr | missense_variant, splice_region_variant | 13/21 | ENSP00000499585 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151976Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000300 AC: 7AN: 233000Hom.: 0 AF XY: 0.0000159 AC XY: 2AN XY: 126106
GnomAD4 exome AF: 0.000110 AC: 160AN: 1450204Hom.: 0 Cov.: 30 AF XY: 0.000103 AC XY: 74AN XY: 720378
GnomAD4 genome AF: 0.0000658 AC: 10AN: 151976Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74224
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 25, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); Alters the last nucleotide of the exon and is predicted to destroy the splice donor site but the effect on protein function is unclear; In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 32579932) - |
Catecholaminergic polymorphic ventricular tachycardia 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 19, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 369 of the TRDN protein (p.Ala369Thr). This variant also falls at the last nucleotide of exon 13, which is part of the consensus splice site for this exon. This variant is present in population databases (rs369198088, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with TRDN-related conditions. ClinVar contains an entry for this variant (Variation ID: 408726). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2023 | The c.1105G>A variant (also known as p.A369T), located in coding exon 13 of the TRDN gene, results from a G to A substitution at nucleotide position 1105. The amino acid change results in alanine to threonine at codon 369, an amino acid with similar properties. However, this change occurs in the last base pair of coding exon 13, which makes it likely to have some effect on normal mRNA splicing. This nucleotide position is highly conserved in available vertebrate species. This amino acid position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site. In addition, as a missense substitution this is predicted to be tolerated by in silico analysis. However, this alteration does not impact the predominant cardiac isoform of TRDN (NM_001256021.1; Kobayashi YM et al. J. Biol. Chem., 1999 Oct;274:28660-8). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Catecholaminergic polymorphic ventricular tachycardia 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Apr 23, 2021 | The TRDN c.1105G>A; p.Ala369Thr variant (rs369198088), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 408726). This variant is found on only eight chromosomes (8/264396 alleles) in the Genome Aggregation Database. The alanine at codon 396 is moderately conserved, and computational analyses predict that this variant is neutral (REVEL: 0.057). However, this variant also occurs in the last nucleotide of exon 13, and computational analyses of splicing (Alamut v.2.11) predict that this variant may impact splicing by weakening the nearby canonical donor splice site, although RNA studies would be required to confirm this. Given the lack of clinical and functional data, the significance of the p.Ala369Thr variant is uncertain at this time. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at